Patent details

EN | LT

Supplementary protection

LT - FARMACINĖS KOMPOZICIJOS, KURIŲ SUDĖTYJE YRA DAPAGLIFLOZINO PROPILENO GLIKOLIO HIDRATAS

EN - PHARMACEUTICAL FORMULATIONS CONTAINING DAPAGLIFLOZIN PROPYLENE GLYCOL HYDRATE

SPC
(11)	Number of the document
(68)	Number of the document	2139494
(21)	Application number for Supplementary Protection Certificate	PA 2020 522
(22)	Date of filing the application	2020-07-10
(41)	Date of publication of the application	2020-07-27
	Date of publication of SPC
(24)	Date of coming into effect of SPC

Applicant
(71)	AstraZeneca AB, 151 85 Södertälje, SE

Grantee
(73)	AstraZeneca AB, 151 85 Södertälje, SE

Attorney or representative
(74)	Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT

Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
(93)	EU/1/16/1108, 2016-07-15

Name of the product protected by the basic patent
(95)	Sasagliptinas ir dapagliflozinas

Legal status
	SPC application published